Atorvastatin reduces malondialdehyde concentrations in patients with polycystic ovary syndrome. [electronic resource]
Producer: 20130125Description: 3951-5 p. digitalISSN:- 1945-7197
- Adult
- Atorvastatin
- Double-Blind Method
- Female
- Heptanoic Acids -- pharmacology
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors -- pharmacology
- Hypoglycemic Agents -- pharmacology
- Insulin Resistance
- Malondialdehyde -- blood
- Metformin -- pharmacology
- Oxidative Stress -- drug effects
- Polycystic Ovary Syndrome -- blood
- Pyrroles -- pharmacology
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.